In a recent study posted to the bioRxiv* server, researchers used a non-human primate model to show that Sotrovimab, a commercial monoclonal antibody (mAb) also known as Xevudy, was fully effective ...
AUSTIN, Texas -- Texas' health services department is warning that five of its regional infusion centers have run out of the only monoclonal antibody treatment known to be effective against the ...
Please provide your email address to receive an email when new articles are posted on . The monoclonal antibody sotrovimab is no longer authorized by the FDA to treat COVID-19 in certain U.S. regions ...
SAN FRANCISCO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the UK’s National Institute for Health and Care Excellence (NICE) provided positive final ...
The unprecedented COVID-19 pandemic has claimed more than 5 million lives globally since it emerged in Wuhan, China, in late December 2019. The causative agent, severe acute respiratory syndrome ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback